Michael Gelband’s DarioHealth DRIO Stock Holding History

Michael Gelband’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,706	Closed	-$657K	–	2459
2021 Q1	$657K	Buy	+1,706	New	+$769K	0.01%	1174

Other funds holding DRIO

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.97B AUM 43.46% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Fidelity International

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Michael Gelband's DRIO Position: Q2 2021 in Review

Michael Gelband sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 1,706 shares — an estimated $657K sold.

Michael Gelband first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $657K in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

Michael Gelband reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 1,706 DarioHealth shares in Q2 2021, an estimated $657K.
Michael Gelband first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
Michael Gelband's DarioHealth position peaked at $657K in Q1 2021.
58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.